Hypoxia Pretreatment of Bone Marrow-Derived Mesenchymal Stem Cells Seeded in a Collagen-Chitosan Sponge Scaffold Promotes Skin Wound Healing in Diabetic Rats with Hindlimb Ischemia.

Chuan Tong,Haojie Hao,Lei Xia,Jiejie Liu,Dongdong Ti,Liang Dong,Qian Hou,Haijing Song,Huiling Liu,Yali Zhao,Xiaobing Fu,Weidong Han
DOI: https://doi.org/10.1111/wrr.12369
2015-01-01
Wound Repair and Regeneration
Abstract:Bone marrow-derived mesenchymal stem cells (BM-MSCs) have properties that make them promising for the treatment of chronic nonhealing wounds. The major challenge is ensuring an efficient, safe, and painless delivery of BM-MSCs. Tissue-engineered skin substitutes have considerable benefits in skin damage resulting from chronic nonhealing wounds. Here, we have constructed a three-dimensional biomimetic scaffold known as collagen-chitosan sponge scaffolds (CCSS) using the cross-linking and freeze-drying method. Scanning electron microscopy images showed that CCSS had an interconnected network pore configuration about 100 μm and exhibited a suitable swelling ratio for maintaining morphological stability and appropriate biodegradability to improve biostability using swelling and degradation assays. Furthermore, BM-MSCs were seeded in CCSS using the two-step seeding method to construct tissue-engineered skin substitutes. In addition, in this three-dimensional biomimetic CCSS, BM-MSCs secreted their own collagen and maintain favorable survival ability and viability. Importantly, BM-MSCs exhibited a significant upregulated expression of proangiogenesis factors, including HIF-1α, VEGF, and PDGF following hypoxia pretreatment. In vivo, hypoxia pretreatment of the skin substitute observably accelerated wound closure via the reduction of inflammation and enhanced angiogenesis in diabetic rats with hindlimb ischemia. Thus, hypoxia pretreatment of the skin substitutes can serve as ideal bioengineering skin substitutes to promote optimal diabetic skin wound healing.
What problem does this paper attempt to address?